These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 3396622)
1. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Bülau P; Paar WD; von Unruh GE Eur J Clin Pharmacol; 1988; 34(3):311-3. PubMed ID: 3396622 [TBL] [Abstract][Full Text] [Related]
2. Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol. von Unruh GE; Paar WD Biomed Environ Mass Spectrom; 1986 Dec; 13(12):651-6. PubMed ID: 2952188 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations. Kristensen O; Klitgaard NA; Jönsson B; Sindrup S Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oxcarbazepine in the dog. Schicht S; Wigger D; Frey HH J Vet Pharmacol Ther; 1996 Feb; 19(1):27-31. PubMed ID: 8992022 [TBL] [Abstract][Full Text] [Related]
6. First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite. Dickinson RG; Hooper WD; Dunstan PR; Eadie MJ Eur J Clin Pharmacol; 1989; 37(1):69-74. PubMed ID: 2591466 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Ohman I; Vitols S; Tomson T Epilepsia; 2005 Oct; 46(10):1621-4. PubMed ID: 16190933 [TBL] [Abstract][Full Text] [Related]
8. Use of saliva for monitoring oxcarbazepine therapy in epileptic patients. Klitgaard NA; Kristensen O Eur J Clin Pharmacol; 1986; 31(1):91-4. PubMed ID: 3780834 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of oxcarbazepine. May TW; Korn-Merker E; Rambeck B Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593 [TBL] [Abstract][Full Text] [Related]
11. Transplacental passage of oxcarbazepine and its metabolites in vivo. Myllynen P; Pienimäki P; Jouppila P; Vähäkangas K Epilepsia; 2001 Nov; 42(11):1482-5. PubMed ID: 11879354 [TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647 [TBL] [Abstract][Full Text] [Related]
13. Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state. Cardot JM; Degen P; Flesch G; Menge P; Dieterle W Biopharm Drug Dispos; 1995 Oct; 16(7):603-14. PubMed ID: 8785383 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Ohman I; Vitols S; Tomson T Epilepsia; 2000 Jun; 41(6):709-13. PubMed ID: 10840403 [TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine treatment during breast-feeding: a case report. Lutz UC; Wiatr G; Gaertner HJ; Bartels M J Clin Psychopharmacol; 2007 Dec; 27(6):730-2. PubMed ID: 18004156 [No Abstract] [Full Text] [Related]
16. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy. Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy. Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326 [TBL] [Abstract][Full Text] [Related]
18. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989 [TBL] [Abstract][Full Text] [Related]
19. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy. Sattler A; Schaefer M; May TW Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects. Flesch G; Tudor D; Denouel J; Bonner J; Camisasca R Int J Clin Pharmacol Ther; 2003 Jul; 41(7):299-308. PubMed ID: 12875346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]